CARD14E138A signalling in keratinocytes induces TNF-dependent skin and systemic inflammation
| dc.contributor.author | Manils Pacheco, Joan | |
| dc.contributor.author | Webb, Louise V. | |
| dc.contributor.author | Howes, Ashleigh | |
| dc.contributor.author | Janzen, Julia | |
| dc.contributor.author | Boeing, Stefan | |
| dc.contributor.author | Bowcock, Anne M. | |
| dc.contributor.author | Ley, Steven C. | |
| dc.date.accessioned | 2025-05-19T14:49:08Z | |
| dc.date.available | 2025-05-19T14:49:08Z | |
| dc.date.issued | 2020-06-29 | |
| dc.date.updated | 2025-05-19T14:49:09Z | |
| dc.description.abstract | To investigate how the CARD14E138A psoriasis-associated mutation induces skin inflammation, a knock-in mouse strain was generated that allows tamoxifen-induced expression of the homologous Card14E138A mutation from the endogenous mouse Card14 locus. Heterozygous expression of CARD14E138A rapidly induced skin acanthosis, immune cell infiltration and expression of psoriasis-associated pro-inflammatory genes. Homozygous expression of CARD14E138A induced more extensive skin inflammation and a severe systemic disease involving infiltration of myeloid cells in multiple organs, temperature reduction, weight loss and organ failure. This severe phenotype resembled acute exacerbations of generalised pustular psoriasis (GPP), a rare form of psoriasis that can be caused by CARD14 mutations in patients. CARD14E138A-induced skin inflammation and systemic disease were independent of adaptive immune cells, ameliorated by blocking TNF and induced by CARD14E138A signalling only in keratinocytes. These results suggest that anti-inflammatory therapies specifically targeting keratinocytes, rather than systemic biologicals, might be effective for GPP treatment early in disease progression. | |
| dc.format.extent | 32 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 723848 | |
| dc.identifier.issn | 2050-084X | |
| dc.identifier.pmid | 32597759 | |
| dc.identifier.uri | https://hdl.handle.net/2445/221115 | |
| dc.language.iso | eng | |
| dc.publisher | eLife Sciences | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.7554/eLife.56720 | |
| dc.relation.ispartof | eLife, 2020, vol. 9 | |
| dc.relation.uri | https://doi.org/10.7554/eLife.56720 | |
| dc.rights | cc-by (c) Manils, Joan et al., 2020 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | |
| dc.subject.classification | Psoriasi | |
| dc.subject.classification | Pèptids | |
| dc.subject.classification | Dermatitis | |
| dc.subject.classification | Animals | |
| dc.subject.other | Psoriasis | |
| dc.subject.other | Peptides | |
| dc.subject.other | Dermatitis | |
| dc.subject.other | Animals | |
| dc.title | CARD14E138A signalling in keratinocytes induces TNF-dependent skin and systemic inflammation | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1